| Literature DB >> 28947678 |
John Paul Walsh1,2, Amy Coates1, Fabio Lima3, Rob Smith1, Georgios Oikonomou1,4.
Abstract
The objective of this study was to determine the effect on pregnancy outcome of either inseminating heifers twice (at 48 and 72 hours after withdrawal of a controlled internal drug release insert (CIDR) containing progesterone) or once (56 hours after CIDR withdrawal) following a seven-day CIDR synchronisation protocol. Dairy heifers (n=267) from five farms, with an age range of 388-736 days, were randomly assigned to one of two treatment groups (group A heifers were inseminated twice; group B heifers were inseminated once). Both groups received a CIDR on day (D) 0 and an intramuscular injection of d-cloprostenol on D6; the CIDR was withdrawn on D7. Measurements of withers height, body condition score and hearth girth (used to estimate weight) were taken on D0. The diameter of the largest follicles and corpora lutea was recorded on both D0 and D6. Data were analysed with the use of multivariable logistic regression modelling. Treatment group and farm were not statistically significantly associated with pregnancy per treatment (P/T). Age and dominant follicle size on D6 were significantly associated with P/T. Heifers with the largest dominant follicle sizes (16-22 mm) were 5.54 times less likely to be pregnant than those heifers with the smallest dominant follicles (8-10 mm) on D6. It was shown that the cost associated with inseminating heifers twice after a seven-day CIDR synchronisation protocol is not justified. © British Veterinary Association (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: CIDR; Dairy Heifer; Fixed Time Artificial Insemination
Mesh:
Substances:
Year: 2017 PMID: 28947678 PMCID: PMC5738605 DOI: 10.1136/vr.104369
Source DB: PubMed Journal: Vet Rec ISSN: 0042-4900 Impact factor: 2.695
Mean (M), sd and range values of age, BCS, height, weight, corpus luteum (CL) size and dominant follicle size at enrolment for different treatment groups
| Variable | Group | N | M | sd | Range | P value |
| Age (days) | A | 119 | 468.7 | 39.1 | 398–617 | 0.586 |
| B | 118 | 465.6 | 47.1 | 388–736 | ||
| BCS (0–5) | A | 119 | 2.88 | 0.31 | 2.25–4.0 | 0.573 |
| B | 118 | 2.90 | 0.30 | 2.0–4.0 | ||
| Height (cm) | A | 119 | 127.9 | 4.8 | 115–138 | 0.110 |
| B | 118 | 126.8 | 5.1 | 116–139 | ||
| Weight (kg) | A | 119 | 408.0 | 58.6 | 314–586 | 0.169 |
| B | 118 | 397.3 | 60.7 | 244–600 | ||
| CL size day 0 (mm) | A | 95 | 21.8 | 5.5 | 10–38 | 0.531 |
| B | 96 | 21.3 | 5.5 | 8–32 | ||
| Follicle size day 0 (mm) | A | 107 | 12.16 | 3.20 | 8–22 | 0.762 |
| B | 95 | 12.03 | 3.02 | 8–22 |
A two-sample t test was used in order to assess the potential significance of any difference.
BCS, body condition score.
Proportion of pregnancies per treatments (P/T) for different quartiles of the variables age, withers height, and dominant follicle size on day 6 and for presence or not of a corpus luteum on day 0
| Variable | Category | Range | P/T | Odds ratio | P value |
| Age (days) | 1 | 388–438 | 0.61 | 0.99 (0.99–1) | 0.044 |
| 2 | 439–464 | 0.60 | |||
| 3 | 465–492 | 0.53 | |||
| 4 | 493–736 | 0.55 | |||
| Withers height (cm) | 1 | 115–123 | 0.50 | 1.10 (1–1.20) | 0.053 |
| 2 | 124–128 | 0.57 | |||
| 3 | 129–131 | 0.56 | |||
| 4 | 132–139 | 0.66 | |||
| Presence of a corpus luteum on day 0 (mm) | Yes | 0.60 | 1.95 (0.92–4.15) | 0.082 | |
| No | 0.44 | Reference | |||
| Dominant follicle size on day 6 (mm) | 1 | 8–10 | 0.67 | 0.84 (0.76–0.92) | <0.001 |
| 2 | 11–12 | 0.64 | |||
| 3 | 13–15 | 0.60 | |||
| 4 | 16–22 | 0.31 |
Odds ratios obtained from multivariable logistic regression modelling are also presented (odds of being pregnant v non-pregnant). Odds ratios for the continuous variables age, withers height and dominant follicle size on day 6 are presented per unit increase.